The Efficacy of Integrated Rehabilitation for Post-Stroke Anxiety: Study Protocol for a Prospective, Multicenter, Randomized Controlled Trial

Jie Zhou, Lijuan Fan, Hantong Hu, Ke Shen, Liya Wu, Xiaoqi Lin, Hong Gao, Jie Zhou, Lijuan Fan, Hantong Hu, Ke Shen, Liya Wu, Xiaoqi Lin, Hong Gao

Abstract

Background: Post-stroke anxiety (PSA) remains a challenging medical problem. Integrated rehabilitation involves a combination of traditional Chinese medicine (TCM) and Western conventional rehabilitation techniques. Theoretically, integrated rehabilitation is likely to have significant advantages in treating PSA. Nevertheless, the therapeutic effect of integrated rehabilitation needs to be verified based on large-scale trials with sound methodology. Thus, the aim of this trial is to assess the efficacy and safety of integrated rehabilitation on PSA.

Methods: The study is a prospective, multicenter, randomized, controlled trial involving 188 PSA patients from four clinical centers in China. Eligible participants will be randomly divided into the integrated rehabilitation group or the standard care group. Participants in the integrated rehabilitation group will receive a combination of TCM and Western conventional rehabilitation methods, including acupuncture, repeated transcranial magnetic stimulation, traditional Chinese herbal medicine, and standard care. The primary outcome will be the Hamilton Anxiety Rating Scale (HAM-A). The secondary outcomes will include the Self-Rating Anxiety Scale (SAS), the Activities of Daily Living (ADL) scale, the Montreal Cognitive Assessment (MoCA) scale, the simplified Fugl-Meyer Assessment of motor function (FMA) scale, and the Pittsburgh Sleep Quality Index (PSQI). Outcome measurements will be performed at baseline, at the end of the 4-week treatment and the 8-week follow-up.

Conclusion: Results of this trial will ascertain the efficacy and safety of integrated rehabilitation on PSA, thereby providing evidence regarding integrated rehabilitation strategies for treating PSA. It will also promote up-to-date evidence for patients, clinicians, and policy-makers.

Trial registration: ClinicalTrials.gov NCT05147077.

Keywords: Western medicine; post-stroke anxiety; randomized controlled trial; rehabilitation; repeated transcranial magnetic stimulation; traditional Chinese medicine.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022 Zhou et al.

Figures

Figure 1
Figure 1
Flow chart of the study process.

References

    1. Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447–454. doi:10.1161/CIR.0000000000000366
    1. Feigin VL, Nguyen G, Cercy K, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429–2437.
    1. Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394–405. doi:10.1016/S1474-4422(18)30500-3
    1. Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771. doi:10.1161/CIRCULATIONAHA.116.025250
    1. Sanner Beauchamp JE, Casameni Montiel T, Cai C, et al. A Retrospective study to identify novel factors associated with post-stroke anxiety. J Stroke Cerebrovasc Dis. 2020;29(2):104582. doi:10.1016/j.jstrokecerebrovasdis.2019.104582
    1. Almhdawi KA, Alazrai A, Kanaan S, et al. Post-stroke depression, anxiety, and stress symptoms and their associated factors: a cross-sectional study. Neuropsychol Rehabil. 2021;31(7):1091–1104. doi:10.1080/09602011.2020.1760893
    1. Ryan BJ, Clunne SM, Baker CJ, Shiggins C, Rose ML, Kneebone II. A systematic review of non-drug interventions to prevent and treat anxiety in people with aphasia after stroke. Disabil Rehabil. 2021;1–10. doi:10.1080/09638288.2021.1925752
    1. Knapp P, Campbell Burton CA, Holmes J, et al. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2017;5(5):Cd008860. doi:10.1002/14651858.CD008860.pub3
    1. Golding K, Fife-Schaw C, Kneebone I. Twelve month follow-up on a randomised controlled trial of relaxation training for post-stroke anxiety. Clin Rehabil. 2017;31(9):1164–1167. doi:10.1177/0269215516682820
    1. MacPherson H, Peters D, Zollman C. Closing the evidence gap in integrative medicine. BMJ. 2009;339:b3335. doi:10.1136/bmj.b3335
    1. Fang J, Chen L, Ma R, et al. Comprehensive rehabilitation with integrative medicine for subacute stroke: a multicenter randomized controlled trial. Sci Rep. 2016;6:25850. doi:10.1038/srep25850
    1. Lee MJ, Yun YJ, Yu SA, et al. Integrative medicine rehabilitation for children with cerebral palsy: a study protocol for a multicenter pragmatic randomized controlled trial. Trials. 2020;21(1):723. doi:10.1186/s13063-020-04639-x
    1. Yang XY, Yang NB, Huang FF, Ren S, Li ZJ. Effectiveness of acupuncture on anxiety disorder: a systematic review and meta-analysis of randomised controlled trials. Ann Gen Psychiatry. 2021;20(1):9. doi:10.1186/s12991-021-00327-5
    1. Tong QY, Liu R, Zhang K, Gao Y, Cui GW, Shen WD. Can acupuncture therapy reduce preoperative anxiety? A systematic review and meta-analysis. J Integr Med. 2021;19(1):20–28. doi:10.1016/j.joim.2020.10.007
    1. Kwon CY, Lee B, Chung SY, Kim JW. Herbal medicine for post-stroke anxiety: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract. 2019;35:237–252. doi:10.1016/j.ctcp.2019.02.015
    1. Yang S, Xu Y, Peng W, et al. Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Complement Ther Clin Pract. 2021;45:101470. doi:10.1016/j.ctcp.2021.101470
    1. Cirillo P, Gold AK, Nardi AE, et al. Transcranial magnetic stimulation in anxiety and trauma-related disorders: a systematic review and meta-analysis. Brain Behav. 2019;9(6):e01284. doi:10.1002/brb3.1284
    1. Kozel FA. Clinical repetitive transcranial magnetic stimulation for posttraumatic stress disorder, generalized anxiety disorder, and bipolar disorder. Psychiatr Clin North Am. 2018;41(3):433–446. doi:10.1016/j.psc.2018.04.007
    1. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi:10.7326/0003-4819-158-3-201302050-00583
    1. Wang Y, Han S, Qin H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population. Stroke Vasc Neurol. 2020;5(3):270–278. doi:10.1136/svn-2020-000385
    1. Zhang T, Zhao J, Li X, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of stroke rehabilitation. Stroke Vasc Neurol. 2020;5(3):250–259. doi:10.1136/svn-2019-000321
    1. Chinese Psychiatric Society. The Chinese Classification of Mental Disorders. 3rd [CCMD‐3] ed. Shandong: Shandong Publishing House of Science and Technology; 2001.
    1. Maier W, Buller R, Philipp M, Heuser I. The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14(1):61–68. doi:10.1016/0165-0327(88)90072-9
    1. Mikami K, Jorge RE, Moser DJ, et al. Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy. J Neuropsychiatry Clin Neurosci. 2014;26(4):323–328. doi:10.1176/appi.neuropsych.11020047
    1. Kimura M, Tateno A, Robinson RG. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. Am J Geriatr Psychiatry. 2003;11(3):320–327. doi:10.1097/00019442-200305000-00009
    1. Bruss GS, Gruenberg AM, Goldstein RD, Barber JP. Hamilton Anxiety Rating Scale Interview guide: joint interview and test-retest methods for interrater reliability. Psychiatry Res. 1994;53(2):191–202. doi:10.1016/0165-1781(94)90110-4
    1. Dunstan DA, Scott N, Todd AK. Screening for anxiety and depression: reassessing the utility of the Zung scales. BMC Psychiatry. 2017;17(1):329. doi:10.1186/s12888-017-1489-6
    1. Dunstan DA, Scott N. Norms for Zung’s self-rating anxiety scale. BMC Psychiatry. 2020;20(1):90. doi:10.1186/s12888-019-2427-6
    1. Han G, Maruta M, Ikeda Y, et al. Relationship between performance on the mini-mental state examination sub-items and activities of daily living in patients with Alzheimer’s disease. J Clin Med. 2020;9(5):1537. doi:10.3390/jcm9051537
    1. Okabe K, Nagata T, Shinagawa S, et al. Effects of neuropsychiatric symptoms of dementia on reductions in activities of daily living in patients with Alzheimer’s disease. Geriatr Gerontol Int. 2020;20(6):584–588. doi:10.1111/ggi.13918
    1. Feng Y, Zhang J, Zhou Y, Chen B, Yin Y. Concurrent validity of the short version of Montreal Cognitive Assessment (MoCA) for patients with stroke. Sci Rep. 2021;11(1):7204. doi:10.1038/s41598-021-86615-2
    1. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
    1. Petkus AJ, Reynolds CA, Wetherell JL, Kremen WS, Gatz M. Temporal dynamics of cognitive performance and anxiety across older adulthood. Psychol Aging. 2017;32(3):278–292. doi:10.1037/pag0000164
    1. Hijikata N, Kawakami M, Ishii R, et al. Item difficulty of Fugl-Meyer assessment for upper extremity in persons with chronic stroke with moderate-to-severe upper limb impairment. Front Neurol. 2020;11:577855. doi:10.3389/fneur.2020.577855
    1. See J, Dodakian L, Chou C, et al. A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials. Neurorehabil Neural Repair. 2013;27(8):732–741. doi:10.1177/1545968313491000
    1. Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The Pittsburgh Sleep Quality Index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev. 2016;25:52–73. doi:10.1016/j.smrv.2015.01.009
    1. Xiao M, Huang G, Feng L, et al. Impact of sleep quality on post-stroke anxiety in stroke patients. Brain Behav. 2020;10(12):e01716. doi:10.1002/brb3.1716
    1. Liu F, Yang Y, Wang S, et al. Impact of sleep duration on depression and anxiety after acute ischemic stroke. Front Neurol. 2021;12:630638. doi:10.3389/fneur.2021.630638
    1. Schmid AA, Kroenke K, Hendrie HC, Bakas T, Sutherland JM, Williams LS. Poststroke depression and treatment effects on functional outcomes. Neurology. 2011;76(11):1000–1005. doi:10.1212/WNL.0b013e318210435e
    1. Ford CE, Malley D, Bateman A, Clare IC, Wagner AP, Gracey F. Selection and visualisation of outcome measures for complex post-acute acquired brain injury rehabilitation interventions. NeuroRehabilitation. 2016;39(1):65–79. doi:10.3233/NRE-161339
    1. Naghavi FS, Koffman EE, Lin B, Du J. Post-stroke neuronal circuits and mental illnesses. Int J Physiol Pathophysiol Pharmacol. 2019;11(1):1–11.
    1. Villain M, Cosin C, Glize B, et al. Affective prosody and depression after stroke: a pilot study. Stroke. 2016;47(9):2397–2400. doi:10.1161/STROKEAHA.116.013852
    1. Adomavičienė A, Daunoravičienė K, Kubilius R, Varžaitytė L, Raistenskis J. Influence of new technologies on post-stroke rehabilitation: a comparison of Armeo Spring to the Kinect system. Medicina. 2019;55(4):98. doi:10.3390/medicina55040098
    1. Wu P, Liu S. Clinical observation on post-stroke anxiety neurosis treated by acupuncture. J Tradit Chin Med. 2008;28(3):186–188. doi:10.1016/S0254-6272(08)60043-6
    1. Aidar FJ, Jacó de Oliveira R, Gama de Matos D, et al. A randomized trial of the effects of an aquatic exercise program on depression, anxiety levels, and functional capacity of people who suffered an ischemic stroke. J Sports Med Phys Fitness. 2018;58(7–8):1171–1177. doi:10.23736/S0022-4707.17.07284-X
    1. Rao V, Bergey A, Rosenberg P. Sertraline for treatment of post-stroke anxiety. J Neuropsychiatry Clin Neurosci. 2012;24(2):E22. doi:10.1176/appi.neuropsych.11060134
    1. Golding K, Kneebone I, Fife-Schaw C. Self-help relaxation for post-stroke anxiety: a randomised, controlled pilot study. Clin Rehabil. 2016;30(2):174–180. doi:10.1177/0269215515575746
    1. Zhang SH, Wang YL, Zhang CX, et al. Effect of interactive dynamic scalp acupuncture on post-stroke cognitive function, depression, and anxiety: a multicenter, randomized, controlled trial. Chin J Integr Med. 2022;28(2):106–115. doi:10.1007/s11655-021-3338-1
    1. Amorim D, Amado J, Brito I, et al. Acupuncture and electroacupuncture for anxiety disorders: a systematic review of the clinical research. Complement Ther Clin Pract. 2018;31:31–37. doi:10.1016/j.ctcp.2018.01.008
    1. Ma CH, Li LSW, Kwok LP, et al. A retrospective, cross sectional controlled study of Chinese medicine for post-stroke rehabilitation. J Neurol Sci. 2017;381:923. doi:10.1016/j.jns.2017.08.2595
    1. Lefaucheur JP, Andre-Obadia N, Poulet E, et al. French guidelines on the use of repetitive transcranial magnetic stimulation (rTMS): safety and therapeutic indications. Neurophysiol Clin. 2011;41(5–6):221–295. doi:10.1016/j.neucli.2011.10.062
    1. Sagliano L, Atripaldi D, De Vita D, D’Olimpio F, Trojano L. Non-invasive brain stimulation in generalized anxiety disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2019;93:31–38. doi:10.1016/j.pnpbp.2019.03.002

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa